Halozyme Therapeutics (HALO) Invested Capital (2012 - 2026)
Halozyme Therapeutics' Invested Capital came in at $2.29 billion for Q2 2026, up 24.3% from $1.84 billion a year earlier but down 3.1% from the prior quarter.
Halozyme Therapeutics (HALO) Invested Capital (2012 - 2026) Analysis & Trends
For FY2025, Halozyme Therapeutics' Invested Capital was $2.19 billion, up 17.2% from FY2024.
- Invested Capital carries a five-year compound annual growth rate of 31.9% (FY2020 to FY2025).
- Going back by year, Invested Capital was $1.87 billion in FY2024 (+18.1%), $1.58 billion in FY2023 (-5.5%), $1.68 billion in FY2022 (+56.1%) and $1.07 billion in FY2021 (+95.8%).
- The five-year range for quarterly Invested Capital is $349.8 million (Q1 2022) to $2.36 billion (Q1 2026).
- Year-over-year, Invested Capital has increased for ten consecutive quarters, with growth averaging 14.3% over the last eight quarters.
- The fastest year-over-year change in Invested Capital over five years came in Q1 2023 (growth of 346.0%), and the weakest in Q4 2023 (a decline of 5.5%).
- Business Quant data shows HALO's Invested Capital at $2.36 billion (Q1 2026), $2.19 billion (Q4 2025) and $2.01 billion (Q3 2025) in the three quarters before Q2 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 88.79 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 134.01 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 64.89 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 95.89 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 79.44 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 50.26 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 68.99 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 38.08 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 148.69 Bn |
| 10 | Halozyme Therapeutics | 12.53 Bn | 11.13 Bn | 401.83 Mn | 2.29 Bn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 2.29 Bn |
| Mar 31, 2026 | 2.36 Bn |
| Dec 31, 2025 | 2.19 Bn |
| Sep 30, 2025 | 2.01 Bn |
| Jun 30, 2025 | 1.84 Bn |
| Mar 31, 2025 | 1.99 Bn |
| Dec 31, 2024 | 1.87 Bn |
| Sep 30, 2024 | 1.96 Bn |
| Jun 30, 2024 | 1.79 Bn |
| Mar 31, 2024 | 1.68 Bn |
| Dec 31, 2023 | 1.58 Bn |
| Sep 30, 2023 | 1.75 Bn |
| Jun 30, 2023 | 1.65 Bn |
| Mar 31, 2023 | 1.56 Bn |
| Dec 31, 2022 | 1.68 Bn |
| Sep 30, 2022 | 1.60 Bn |
| Jun 30, 2022 | 392.22 Mn |
| Mar 31, 2022 | 349.80 Mn |
| Dec 31, 2021 | 1.07 Bn |
| Sep 30, 2021 | 370.93 Mn |
Halozyme Therapeutics Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=HALO&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "HALO", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=HALO&period=max&api_key=YOUR_API_KEY");
const data = await res.json();